Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Loxo Oncology, Inc. (LOXO)

« Back to company index

LOXO Chatter Timeline

Stock Ticker for LOXO

Most Active Tweeters for LOXO

UserTweets
@lblegend33 1
@HenryJOncology 1

Recent Tweets for LOXO

HenryJOncology @HenryJOncology
What predictive model did $LLY use to think that this was a good idea? This is why I liked $loxo as a stand-alone. https://t.co/RW5ZoS54ld
October 16th 2019, 8:10pm
lblegend33 @lblegend33
@_B_I_O_T_E_C_H_ Said the same thing when Bayer partnered w $loxo
October 16th 2019, 8:10am
StevElms @StevElms
So proud of the $LOXO team continuing to provide therapies for cancer patients. https://t.co/Sy9Krd25Ve
September 29th 2019, 6:09pm
GautschiOliver @GautschiOliver
@VivekSubbiah Big credit to Michael Rothenberg. Very impressed by the drug and the people behind it $LOXO
September 29th 2019, 3:09pm
BigChodu @BigChodu
@melty1 @srqstockpicker $loxo buyout started that explosive run
September 26th 2019, 2:09pm
StockTipRobot @StockTipRobot
My robot friend Sergei (who is totally not a Russian bot) says to exit Loxo Oncology $LOXO #StockMarket
September 24th 2019, 8:09pm
StockTipRobot @StockTipRobot
Rigorous analysis I didn't conduct says to buy, sell, and hold Loxo Oncology $LOXO #JustSaying
September 21st 2019, 1:09am
JunkieBiotech @JunkieBiotech
@matthewherper Good for Josh and Jake. I passed on so many rounds of funding and each time it was a bad decision. $lly $loxo
September 9th 2019, 11:09pm
SlingshotCtlyst @SlingshotCtlyst
Selpercatinib (LOXO-292) shows a 68 Percent Objective Response Rate and Sustained Durability in Heavil $LLY , $LOXO https://t.co/TSs65YDcR6
September 9th 2019, 10:09am
BioDueDiligence @BioDueDiligence
RT @BursatilBiotech: First time: is luck Second time: you're getting good. More than 3 times: you're definitely good. Nice job, $LOXO $L…
September 9th 2019, 8:09am
BursatilBiotech @BursatilBiotech
First time: is luck Second time: you're getting good. More than 3 times: you're definitely good. Nice job, $LOXO… https://t.co/kVvLtLAWSV
September 9th 2019, 7:09am
davidschull @davidschull
RT @BioPharmaDive: Former $LOXO CEO finds himself in charge of the pharma's cancer research and early drug development months after $LLY's…
August 9th 2019, 8:08am
BioPharmaDive @BioPharmaDive
Former $LOXO CEO finds himself in charge of the pharma's cancer research and early drug development months after… https://t.co/CGahiO27fu
August 8th 2019, 2:08pm
Gambiste1 @Gambiste1
RT @NedPagliarulo: In place of Garraway at $LLY, Josh Bilenker, the CEO of Lilly-acquired $LOXO, will fill the role in the interim
August 7th 2019, 6:08pm
Gambiste1 @Gambiste1
RT @BioPharmaDive: Former $LOXO CEO Josh Bilenker now finds himself in charge of $LLY's cancer research and early stage drug development…
August 7th 2019, 6:08pm
BioPharmaDive @BioPharmaDive
Former $LOXO CEO Josh Bilenker now finds himself in charge of $LLY's cancer research and early stage drug developme… https://t.co/7wt5TCs9Zr
August 7th 2019, 5:08pm
Boston_Biotech @Boston_Biotech
RT @bio_clouseau: $LLY Former $LOXO CEO promoted to lead oncology research for now https://t.co/WxKwvAznme
August 7th 2019, 10:08am
NedPagliarulo @NedPagliarulo
In place of Garraway at $LLY, Josh Bilenker, the CEO of Lilly-acquired $LOXO, will fill the role in the interim
August 7th 2019, 9:08am
bio_clouseau @bio_clouseau
$LLY Former $LOXO CEO promoted to lead oncology research for now https://t.co/WxKwvAznme
August 7th 2019, 9:08am
DZalkowitz @DZalkowitz
@OnlyBios If price was the measure, you wouldn't get 100 point moves like $LOXO after the data is released.
August 1st 2019, 10:08pm
joaquinkam @joaquinkam
Since my underlying thesis is that $PTLA is an acquisition target. Driver= Pipeline. That was the case W/ $LOXO… https://t.co/Bkr0nawDzS
July 30th 2019, 1:07pm
portefeuillefun @portefeuillefun
$BAYN $LOXO. https://t.co/OKQZM9OmTP
July 26th 2019, 6:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.